Vetoquinol - Universal Registration Document - 2021

2 STATEMENT OF NON-FINANCIAL PERFORMANCE 2.1 A STRATEGY ENCOMPASSING CORPORATE SOCIAL RESPONSIBILITY (CSR) 27 2.2 SUSTAINABLE DEVELOPMENT GOALS AT VETOQUINOL 27 2.3 OVERALL HEALTH, SAFETY AND ENVIRONMENTAL POLICY 30 2.3.1 HSE department structure within the Group 31 2.3.2 Development of internal HSE standards 31 2.3.3 Control of HSE risks at the core of our business 31 2.4 VETOQUINOL’S PEOPLE 32 2.4.1 Headcount analysis at December 31, 2020 32 2.4.2 Health and safety in the workplace 35 2.4.3 Attractiveness as an employer 38 2.4.4 Recruitment, induction and compensation 39 2.4.5 Organization of staff dialog 40 2.4.6 Training 41 2.4.7 Non-discrimination and equal opportunities 42 2.4.8 Work organization 43 2.5 CARBON FOOTPRINT 43 2.5.1 Prevention of pollution 43 2.5.2 Waste management 44 2.5.3 Sustainable use of resources: water and energy 45 2.5.4 Atmospheric emissions and climate change 48 2.5.5 Protection of biodiversity 48 2.6 OUR PRODUCTS 49 2.6.1 Overview of the R&D process 49 2.6.2 Vetoquinol Group R&D strategy 50 2.6.3 Organization of Vetoquinol’s scientific division 51 2.6.4 Overview of current R&D programs 52 2.6.5 Risk of dependence on human health research to develop new molecules 52 2.6.6 Antibiotics for veterinary use and antibioresistance: commitment to the rational use of antibiotics in animal health 53 2.6.7 Eco-friendly products 53 2.7 SOCIAL FOOTPRINT 54 2.7.1 Territorial, economic and social impact of the Group’s business 54 2.7.2 Animal welfare 55 2.7.3 Humans and animals: a lifelong relationship 56 2.7.4 Ethics and fair practices 57 2.7.5 Supplier relations 58 2.8 AUDITOR’S REPORT 59 Vetoquinol Universal Registration Document 2020 Financial report 27